Form 4: Intuitive Surgical Executive Robert DeSantis Executes Stock Options and Sells Shares Under 10b5-1 Trading Plan

Robert DeSantis, EVP & Chief Strategy & Corp Op at Intuitive Surgical, executed stock options and sold shares of common stock under a pre-arranged 10b5-1 trading plan.

Summary

• Robert DeSantis, an executive at Intuitive Surgical, engaged in multiple transactions involving the company's common stock.
• These transactions included the exercise of non-qualified stock options and restricted stock units (RSUs), as well as the sale of common stock.
• The sales were executed under a pre-arranged trading plan that complies with SEC Rule 10b5-1.
• On May 10, 2024, DeSantis exercised options to acquire 120 shares at $304.67 and 119 shares at $229.39, then sold 120 shares at $385.55 and 119 shares at $385.55.
• On May 11, 2024, DeSantis exercised RSUs for 360 shares and sold 167 shares at $386.7 to cover tax withholding.
• On May 13, 2024, DeSantis exercised options to acquire 90 shares at $179.7, then sold 90 shares at $389.16 and 194 shares at $389.16.
• Following these transactions, DeSantis directly owns 5,506 shares of Intuitive Surgical common stock.

Sentiment

Score: 6

Explanation: Neutral sentiment. The transactions are part of a pre-planned trading strategy, so they don't necessarily reflect a change in the executive's outlook on the company. The sales could be seen as slightly negative, but the option exercises are a positive sign.

Positives

• The executive is exercising options, indicating a belief in the company's long-term value.
• The use of a 10b5-1 trading plan suggests transparency and avoids concerns about insider trading.

Negatives

• The executive is selling shares, which could be perceived negatively by some investors, although it's part of a pre-planned strategy.

Risks

• Executive stock sales, even under a 10b5-1 plan, can sometimes create short-term downward pressure on the stock price.
• Changes in executive holdings could be interpreted as a shift in sentiment, although this is mitigated by the pre-planned nature of the sales.

Future Outlook

The executive will likely continue to execute stock options and sell shares under the 10b5-1 trading plan until its expiration on December 9, 2024.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies like Intuitive Surgical. Monitoring these transactions can provide insights into management's perspective on the company's valuation and future prospects.

Comparison to Industry Standards

• Executive compensation practices, including stock options and RSUs, are standard across the medical device industry.
• Companies like Medtronic, Stryker, and Johnson & Johnson also utilize similar equity-based compensation to align executive interests with shareholder value.
• The vesting schedules and terms of the options and RSUs are generally in line with industry norms for executive compensation packages.

Stakeholder Impact

• Shareholders may react to the stock sales, although the pre-planned nature of the transactions should mitigate any significant concerns.
• Employees may view the executive's stock transactions as a reflection of the company's performance and prospects.

Next Steps

• Monitor future Form 4 filings to track further transactions by the executive.
• Assess the overall impact of executive stock transactions on market sentiment.

Key Dates